Luka Dončić: Everything you need to know

Luka Dončić

#77 PG

Los Angeles Lakers

Status

GTD - Hamstring - Strain Expected Return: 2026-10-01

STATS

Career Averages

PTS

REB

AST

BLK

STL

29.2

8.5

8.2

0.5

1.3

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	64	64	35.8	33.5	7.7	8.3	0.5	1.6	4.0	34	8	4.0	10.8	36.6%	6.9	11.9	57.5%	10.8	22.8	47.6%	7.9	10.1	78.0%	0.6	7.1	2.4	2.1	+187	61.6%
2024-25	50	50	35.4	28.2	8.2	7.7	0.4	1.8	3.6	21	5	3.5	9.6	36.8%	5.7	10.9	52.2%	9.2	20.5	45.0%	6.2	7.9	78.2%	0.8	7.4	2.5	2.1	+344	58.7%
2023-24	70	70	37.5	33.9	9.2	9.8	0.5	1.4	4.0	49	21	4.1	10.6	38.2%	7.4	13.0	57.3%	11.5	23.6	48.7%	6.8	8.7	78.6%	0.8	8.4	2.1	2.4	+319	61.7%
2022-23	66	66	36.2	32.4	8.6	8.0	0.5	1.4	3.6	36	10	2.8	8.2	34.2%	8.1	13.8	58.8%	10.9	22.0	49.6%	7.8	10.5	74.2%	0.8	7.8	2.5	2.2	+128	60.9%
2021-22	65	65	35.4	28.4	9.1	8.7	0.6	1.2	4.5	44	10	3.1	8.8	35.3%	6.8	12.8	52.8%	9.9	21.6	45.7%	5.6	7.5	74.4%	0.9	8.3	2.2	1.9	+146	57.1%
2020-21	66	66	34.3	27.7	8.0	8.6	0.5	1.0	4.3	26	11	2.9	8.3	35.0%	6.9	12.2	56.7%	9.8	20.5	47.9%	5.2	7.1	73.0%	0.8	7.2	2.3	2.0	+164	58.7%
2019-20	61	61	33.6	28.8	9.4	8.8	0.2	1.0	4.3	39	17	2.8	8.9	31.6%	6.7	11.7	57.4%	9.5	20.6	46.3%	7.0	9.2	75.8%	1.3	8.1	2.5	2.1	+253	58.5%
2018-19	72	72	32.2	21.2	7.8	6.0	0.3	1.1	3.4	24	8	2.3	7.1	32.7%	4.7	9.3	50.3%	7.0	16.5	42.7%	4.8	6.7	71.3%	1.2	6.6	1.9	1.7	-118	54.5%
Career	514	514	35.0	29.2	8.5	8.2	0.5	1.3	4.0	273	90	3.2	9.0	35.2%	6.7	12.0	55.6%	9.8	21.0	46.9%	6.4	8.5	75.5%	0.9	7.6	2.3	2.1	+1423	59.2%

Career Averages

PTS

REB

AST

BLK

STL

30.9

9.2

7.8

0.5

1.6

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2024-25	5	5	41.6	30.2	7.0	5.8	0.6	1.0	4.0	1	0	3.2	9.2	34.8%	6.2	11.6	53.4%	9.4	20.8	45.2%	8.2	9.2	89.1%	0.4	6.6	3.2	1.5	-24	60.8%
2023-24	22	22	40.9	28.9	9.5	8.1	0.4	1.9	4.1	16	7	3.1	9.6	32.2%	7.1	13.3	53.6%	10.2	22.9	44.6%	5.3	7.0	76.5%	0.7	8.7	2.5	2.0	+97	55.6%
2021-22	15	15	36.8	31.7	9.8	6.4	0.6	1.8	3.9	10	0	3.4	9.9	34.5%	7.3	13.6	53.4%	10.7	23.5	45.5%	6.9	9.0	77.0%	0.7	9.1	2.9	1.6	+31	57.7%
2020-21	7	7	40.1	35.7	7.9	10.3	0.4	1.3	4.6	4	1	4.4	10.9	40.8%	9.3	17.1	54.2%	13.7	28.0	49.0%	3.9	7.3	52.9%	0.6	7.3	2.4	2.3	+7	57.2%
2019-20	6	6	35.8	31.0	9.8	8.7	0.5	1.2	5.2	2	2	2.7	7.3	36.4%	8.0	14.0	57.1%	10.7	21.3	50.0%	7.0	10.7	65.6%	0.7	9.2	2.8	1.7	-38	59.6%
Career	55	55	39.2	30.9	9.2	7.8	0.5	1.6	4.2	33	10	3.3	9.5	34.7%	7.5	13.8	54.0%	10.8	23.3	46.1%	6.0	8.2	73.7%	0.7	8.5	2.7	1.8	+73	57.3%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/14	PHX	L 113-104	22	25	7	4	0	0	5	8	4	50.0%	7	3	42.9%	15	7	46.7%	9	7	77.8%	3	4	0.8	+11	3	23	65.9%
Preseason Totals			22.4	25.0	7.0	4.0	0.0	0.0	5.0	8.0	4.0	50.0%	7.0	3.0	42.9%	15.0	7.0	46.7%	9.0	7.0	77.8%	3.0	4.0	0.8	+11	3.0	26.0	65.9%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/2	OKC	L 139-96	25	12	4	7	0	1	6	7	1	14.3%	3	2	66.7%	10	3	30.0%	6	5	83.3%	0	4	1.2	-25	0	13	47.5%
3/31	CLE	W 127-113	33	42	5	12	0	2	0	13	6	46.2%	13	7	53.8%	26	13	50.0%	10	10	100.0%	0	5	0.0	+21	4	51	69.1%
3/27	BKN	W 116-99	38	41	8	3	1	3	5	10	5	50.0%	15	10	66.7%	25	15	60.0%	6	6	100.0%	2	6	0.6	+19	5	39	74.2%
3/25	IND	W 137-130	37	43	6	7	0	1	5	11	4	36.4%	19	11	57.9%	30	15	50.0%	10	9	90.0%	1	5	1.4	+6	5	38	62.5%
3/23	DET	L 113-110	38	32	7	6	0	3	3	13	3	23.1%	16	8	50.0%	29	11	37.9%	8	7	87.5%	1	6	2.0	+7	1	30	49.2%
3/21	ORL	W 105-104	38	33	5	8	1	4	4	13	3	23.1%	17	9	52.9%	30	12	40.0%	9	6	66.7%	1	4	2.0	+10	2	31	48.6%
3/19	MIA	W 134-126	37	60	7	3	0	5	2	17	9	52.9%	13	9	69.2%	30	18	60.0%	19	15	78.9%	1	6	1.5	+7	1	66	78.2%
3/18	HOU	W 124-116	37	40	9	10	0	1	5	17	7	41.2%	8	5	62.5%	25	12	48.0%	14	9	64.3%	0	9	2.0	+2	3	43	64.2%
3/16	HOU	W 100-92	39	36	6	4	0	2	4	12	4	33.3%	15	10	66.7%	27	14	51.9%	5	4	80.0%	0	6	1.0	+6	1	33	61.6%
3/14	DEN	W 127-125	43	30	11	13	3	1	6	14	4	28.6%	12	6	50.0%	26	10	38.5%	9	6	66.7%	0	11	2.2	-4	3	37	50.1%
3/12	CHI	W 142-130	36	51	10	9	1	3	1	14	9	64.3%	17	8	47.1%	31	17	54.8%	9	8	88.9%	0	10	9.0	+15	3	60	72.9%
3/10	MIN	W 120-106	34	31	11	11	1	2	4	12	4	33.3%	12	7	58.3%	24	11	45.8%	6	5	83.3%	0	11	2.8	+20	0	42	58.2%
3/8	NYK	W 110-97	38	35	8	4	0	2	6	16	5	31.3%	9	6	66.7%	25	11	44.0%	10	8	80.0%	0	8	0.7	+14	3	30	59.5%
3/6	IND	W 128-117	31	44	9	5	2	3	3	14	7	50.0%	11	7	63.6%	25	14	56.0%	10	9	90.0%	0	9	1.7	+20	1	53	74.8%
3/5	DEN	L 120-113	40	27	11	7	0	4	3	10	3	30.0%	14	8	57.1%	24	11	45.8%	4	2	50.0%	1	10	2.3	+0	3	31	52.4%
3/3	NOP	W 110-101	37	27	10	7	1	0	7	10	3	30.0%	12	7	58.3%	22	10	45.5%	5	4	80.0%	0	10	1.0	+1	2	27	55.8%
3/1	SAC	W 128-104	29	28	5	9	1	1	1	8	4	50.0%	8	6	75.0%	16	10	62.5%	7	4	57.1%	0	5	9.0	+18	1	39	73.4%
2/28	GSW	W 129-101	29	26	6	8	1	1	2	9	4	44.4%	8	5	62.5%	17	9	52.9%	4	4	100.0%	0	6	4.0	+26	2	32	69.3%
2/26	PHX	L 113-110	39	41	8	8	0	2	3	11	6	54.5%	10	6	60.0%	21	12	57.1%	12	11	91.7%	0	8	2.7	+9	1	52	78.0%
2/24	ORL	L 110-109	37	22	9	15	1	0	2	10	2	20.0%	14	6	42.9%	24	8	33.3%	9	4	44.4%	1	8	7.5	+1	3	26	39.3%
2/22	BOS	L 111-89	32	25	5	3	1	0	2	7	4	57.1%	15	5	33.3%	22	9	40.9%	6	3	50.0%	0	5	1.5	-21	4	18	50.7%
2/20	LAC	W 125-122	37	38	6	11	1	3	2	14	8	57.1%	11	3	27.3%	25	11	44.0%	11	8	72.7%	1	5	5.5	+6	3	46	63.7%
2/5	PHI	W 119-115	15	10	4	2	0	0	5	4	0	0.0%	6	3	50.0%	10	3	30.0%	4	4	100.0%	0	4	0.4	-10	0	6	42.5%
2/3	BKN	W 125-109	28	24	6	5	0	1	5	11	4	36.4%	7	4	57.1%	18	8	44.4%	6	4	66.7%	1	5	1.0	+19	1	21	58.1%
2/1	NYK	L 112-100	36	30	15	8	0	0	3	14	5	35.7%	9	5	55.6%	23	10	43.5%	6	5	83.3%	0	15	2.7	-13	2	37	58.5%
1/30	WAS	W 142-111	30	37	11	13	0	3	5	13	6	46.2%	8	7	87.5%	21	13	61.9%	7	5	71.4%	0	11	2.6	+21	0	53	76.8%
1/28	CLE	L 129-99	29	29	5	6	0	0	2	8	3	37.5%	12	9	75.0%	20	12	60.0%	6	2	33.3%	0	5	3.0	-23	1	28	64.0%
1/26	CHI	W 129-118	38	46	7	12	0	0	3	14	8	57.1%	11	7	63.6%	25	15	60.0%	12	8	66.7%	0	7	4.0	+6	2	51	76.0%
1/24	DAL	W 116-110	39	33	8	11	1	1	5	8	3	37.5%	7	5	71.4%	15	8	53.3%	15	14	93.3%	0	8	2.2	+18	2	48	76.4%
1/22	LAC	L 112-104	39	32	11	8	0	3	1	13	3	23.1%	14	8	57.1%	27	11	40.7%	10	7	70.0%	1	10	8.0	-17	2	40	51.0%
1/20	DEN	W 115-107	35	38	13	10	0	2	3	9	3	33.3%	12	9	75.0%	21	12	57.1%	12	11	91.7%	0	13	3.3	-2	2	53	72.3%
1/18	TOR	W 110-93	33	25	2	7	1	1	4	12	5	41.7%	11	3	27.3%	23	8	34.8%	5	4	80.0%	0	2	1.8	-3	4	13	49.6%
1/15	CHA	L 135-117	35	39	3	4	0	0	1	11	6	54.5%	15	9	60.0%	26	15	57.7%	7	3	42.9%	1	2	4.0	-13	3	32	67.1%
1/13	ATL	W 141-116	33	27	5	12	1	0	7	9	5	55.6%	7	2	28.6%	16	7	43.8%	10	8	80.0%	2	3	1.7	+27	4	30	66.2%
1/12	SAC	L 124-112	36	42	7	8	0	4	4	9	2	22.2%	16	14	87.5%	25	16	64.0%	8	8	100.0%	2	5	2.0	-10	2	50	73.6%
1/9	MIL	L 105-101	36	24	9	9	0	2	3	6	4	66.7%	19	4	21.1%	25	8	32.0%	8	4	50.0%	3	6	3.0	-14	6	21	42.1%
1/7	SAS	L 107-91	38	38	10	10	0	3	7	9	2	22.2%	17	11	64.7%	26	13	50.0%	16	10	62.5%	0	10	1.4	-7	3	43	57.5%
1/6	NOP	W 111-103	37	30	2	10	1	2	5	10	3	30.0%	12	8	66.7%	22	11	50.0%	9	5	55.6%	0	2	2.0	+2	2	32	57.8%
1/4	MEM	W 120-114	38	36	9	8	1	0	3	10	4	40.0%	10	6	60.0%	20	10	50.0%	13	12	92.3%	2	7	2.7	+9	2	45	70.0%
1/2	MEM	W 128-121	37	34	6	8	0	2	6	7	1	14.3%	11	7	63.6%	18	8	44.4%	20	17	85.0%	0	6	1.3	+3	3	39	63.4%
12/30	DET	L 128-106	35	30	5	11	0	0	8	11	3	27.3%	11	6	54.5%	22	9	40.9%	13	9	69.2%	2	3	1.4	-15	3	26	54.1%
12/28	SAC	W 125-101	32	34	5	7	1	3	5	14	5	35.7%	9	6	66.7%	23	11	47.8%	8	7	87.5%	0	5	1.4	+22	3	36	64.1%
12/25	HOU	L 119-96	33	25	5	7	2	1	6	8	3	37.5%	9	6	66.7%	17	9	52.9%	7	4	57.1%	0	5	1.2	-25	2	26	62.3%
12/20	LAC	L 103-88	19	12	5	2	0	0	4	6	1	16.7%	7	3	42.9%	13	4	30.8%	5	3	60.0%	0	5	0.5	-13	1	6	39.5%
12/18	UTA	W 143-135	39	45	11	14	0	5	1	12	4	33.3%	16	10	62.5%	28	14	50.0%	16	13	81.3%	2	9	14.0	-5	2	65	64.2%
12/14	PHX	W 116-114	38	29	3	6	0	1	6	14	2	14.3%	11	5	45.5%	25	7	28.0%	14	13	92.9%	2	1	1.0	-5	3	19	46.5%
12/10	SAS	L 132-119	40	35	5	8	0	1	3	8	3	37.5%	16	8	50.0%	24	11	45.8%	14	10	71.4%	0	5	2.7	-2	5	32	58.0%
12/7	PHI	W 112-108	38	31	15	11	2	0	5	9	2	22.2%	15	7	46.7%	24	9	37.5%	14	11	78.6%	1	14	2.2	+12	1	41	51.4%
12/1	PHX	L 125-108	31	38	11	5	0	0	9	8	3	37.5%	18	12	66.7%	26	15	57.7%	5	5	100.0%	0	11	0.6	-25	2	37	67.4%
11/30	NOP	W 133-121	35	34	12	7	1	1	2	12	4	33.3%	10	5	50.0%	22	9	40.9%	14	12	85.7%	2	10	3.5	+8	0	49	60.4%
11/28	DAL	W 129-119	40	35	5	11	1	0	4	9	4	44.4%	9	6	66.7%	18	10	55.6%	11	11	100.0%	0	5	2.8	+15	4	43	76.6%
11/25	LAC	W 135-118	38	43	9	13	1	1	3	12	7	58.3%	16	7	43.8%	28	14	50.0%	11	8	72.7%	2	7	4.3	+9	4	52	65.5%
11/23	UTA	W 108-106	40	33	11	8	0	3	6	12	3	25.0%	12	7	58.3%	24	10	41.7%	12	10	83.3%	0	11	1.3	+5	2	39	56.4%
11/18	UTA	W 140-126	34	37	5	10	0	4	8	10	2	20.0%	12	9	75.0%	22	11	50.0%	16	13	81.3%	0	5	1.3	+10	4	41	63.7%
11/15	MIL	W 119-95	38	41	9	6	2	1	3	11	5	45.5%	8	4	50.0%	19	9	47.4%	20	18	90.0%	1	8	2.0	+25	1	56	73.7%
11/14	NOP	W 118-104	40	24	7	12	1	2	3	8	3	37.5%	8	3	37.5%	16	6	37.5%	13	9	69.2%	1	6	4.0	+30	1	37	55.2%
11/12	OKC	L 121-92	32	19	7	7	0	2	4	7	1	14.3%	13	6	46.2%	20	7	35.0%	7	4	57.1%	1	6	1.8	-31	3	16	41.2%
11/10	CHA	W 121-111	38	38	6	7	0	1	2	15	5	33.3%	13	9	69.2%	28	14	50.0%	5	5	100.0%	1	5	3.5	+16	4	38	62.9%
11/8	ATL	L 122-102	26	22	5	11	0	1	5	10	4	40.0%	7	3	42.9%	17	7	41.2%	6	4	66.7%	0	5	2.2	-21	2	23	56.0%
11/5	SAS	W 118-116	41	35	9	13	2	5	4	11	4	36.4%	16	5	31.3%	27	9	33.3%	17	13	76.5%	3	6	3.3	+4	5	45	50.8%
11/2	MIA	W 130-120	38	29	11	10	0	3	5	11	1	9.1%	11	8	72.7%	22	9	40.9%	12	10	83.3%	0	11	2.0	+14	1	41	53.2%
10/31	MEM	W 117-112	38	44	12	6	0	0	5	15	6	40.0%	12	8	66.7%	27	14	51.9%	13	10	76.9%	1	11	1.2	-2	3	46	67.2%
10/24	MIN	W 128-110	34	49	11	8	0	0	3	12	5	41.7%	11	9	81.8%	23	14	60.9%	19	16	84.2%	1	10	2.7	+18	4	60	78.1%
10/21	GSW	L 119-109	40	43	12	9	1	2	3	10	2	20.0%	17	15	88.2%	27	17	63.0%	10	7	70.0%	0	12	3.0	-8	1	60	68.5%
Regular Season Totals			35.8	33.5	7.7	8.3	0.5	1.6	4.0	10.8	4.0	36.6%	11.9	6.9	57.5%	22.8	10.8	47.6%	10.1	7.9	78.0%	0.6	7.1	2.1	+187	2.4	40.8	61.6%

Luka Dončić: Breaking News

Doncic (hamstring) said Wednesday that he has started running again, Dan Woike of The Athletic reports. Doncic has been sidelined by a Grade 2 left hamstring strain since April 2. He said he was originally given an eight-week timetable, but he's been doing everything in his power to beat that. He's yet to be cleared for contact and remains week-to-week for the time being, but he's at least trending in the right direction.

Doncic (hamstring) won't be available for the start of the Western Conference Semifinals against Oklahoma City and is considered week-to-week, Shams Charania of ESPN reports. Doncic hasn't been doing "full-fledged running" or participating in full-contact sessions. While the Lakers haven't ruled him out for the series altogether, Charania added that it is still a "slow path" regarding his recovery efforts from a Grade 2 left hamstring strain. The six-time All-Star hasn't played in over a month after suffering the injury in the 139-96 loss to the Thunder on April 2. With Doncic on the shelf, Rui Hachimura is expected to remain in the starting lineup.

Doncic (hamstring) would likely miss the beginning of the Western Conference Semifinals if the Lakers advance past the Rockets, ESPN's Shams Charania reports. After Houston's win on Sunday, the Lakers hold a 3-1 lead over the Rockets and would face the Thunder, who swept the Suns, in the next round if they can win one of the next three games, which appears likely, especially with Kevin Durant (ankle) not expected to suit up. Charania notes that Doncic remains on a slow path to a full recovery. The superstar point guard has ramped up his workload a bit in recent days, but he hasn't been cleared to begin scrimmaging yet. Los Angeles' franchise player has been sidelined since the beginning of April with a Grade 2 hamstring strain.